Linagliptin, a dipeptidyl peptidase-4 inhibitor in development for the treatment of type 2 diabetes mellitus: A phase I, randomized, double-blind, placebo-controlled trial of single and multiple escalating doses in healthy adult male japanese subjects
| Autor: | Sarashina, Akiko, Sesoko, Shogo, Nakashima, Mitsuyoshi, Hayashi, Naoyuki, Taniguchi, Atsushi, Horie, Yoshiharu, Graefe-Mody, Eva U., Woerle, Hans-Juergen, Dugi, Klaus A. |
|---|---|
| Zdroj: | In Clinical Therapeutics 2010 32(6):1188-1204 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect